Endo International | ENDP - Nettoeinkommen



Nettoeinkommen Veränderung Datum
AbbVie USD 1.82B 1.63B 2025-12
Amarin USD -1.22M 6.51M 2025-12
ANI Pharmaceuticals USD 32.35M 6.08M 2025-12
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
Coherus Biosciences USD -37.64M 2.11M 2025-12
Eli Lilly USD 6.64B 1.05B 2025-12
Heron Therapeutics USD -2.95M 14.54M 2025-12
Hikma Pharmaceutical USD 164M 45M 2025-12
Ligand Pharmaceuticals USD 117.27M 112.43M 2025-09
Merck USD 2.96B 2.82B 2025-12
Novartis USD 2.41B 1.52B 2025-12
Pacira USD 1.64M 3.8M 2025-12
Perrigo USD -1.42B 1.43B 2025-12
Pfizer USD -1.65B 5.19B 2025-12
Phibro Animal Health USD 27.46M 932K 2025-12
Supernus Pharmaceuticals USD -45.12M 67.62M 2025-09
Takeda JPY 103.64B 115.44B 2025-12
Teva Pharmaceutical Industries USD 480M 47M 2025-12
Xeris Pharmaceuticals USD 11.08M 10.46M 2025-12
Zoetis USD 603M 118M 2025-12